Zohydro and the Epidemic of Painkiller Abuse
Wednesday, June 18, 2014
In October the Food and Drug Administration approved the controversial long-acting painkiller Zohydro, a drug some doctors think the FDA should never have approved. It belongs to a class of drugs that the Centers for Disease Control and Prevention said has created a nationwide, doctor-driven epidemic of addiction, death, and immeasurable devastation. Stephen S. Hall, New York magazine contributing editor, talks about the drug and the controversy surrounding it in his article “How Much Does it Hurt?” in the June 9 issue of New York.